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Hyperpolarization-activated cyclic nucleotide-regu-
lated (HCN) channels, which generate the Ih current,
mediate a number of important brain functions. The
HCN1 isoform regulates dendritic integration in
cortical pyramidal neurons and provides an inhibitory
constraint on both working memory in prefrontal
cortex and spatial learning and memory in the hippo-
campus. Altered expression of HCN1 following
seizures may contribute to the development of
temporal lobe epilepsy. Yet the regulatory networks
and pathways governing HCN channel expression
and function in the brain are largely unknown. Here,
we report the presence of nine alternative N-terminal
splice forms of the brain-specific cytoplasmic protein
TRIP8b and demonstrate the differential effects of
six isoforms to downregulate or upregulate HCN1
surface expression. Furthermore, we find that all
TRIP8b isoforms inhibit channel opening by shifting
activation to more negative potentials. TRIP8b thus
functions as an auxiliary subunit that provides
a mechanism for the dynamic regulation of HCN1
channel expression and function.
INTRODUCTION
The hyperpolarization-activated cation current (Ih), encoded
by the HCN1–4 gene family, regulates the electrical activity of
a wide array of neurons (for review, Robinson and Siegelbaum,
2003). In cortical layer V and hippocampal CA1 pyramidal
neurons, Ih channels are predominantly composed of HCN1
subunits that are targeted to the distal regions of the apical
dendrites (Santoro et al., 1997; Magee, 1998; Lo¨rincz et al.,
2002). At these sites, Ih inhibits the integration of excitatory
inputs, dendritic excitability and the induction of long-term
synaptic plasticity (Stuart and Spruston, 1998; Magee, 1999;
Williams and Stuart, 2000; Nolan et al., 2004; Tsay et al., 2007;
George et al., 2009). Such effects may underlie the behavioral
role of HCN1 as an inhibitory constraint on hippocampal-depen-802 Neuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc.dent and prefrontal cortex-dependent forms of learning and
memory (Nolan et al., 2004; Wang et al., 2007).
Complementary to the regulatory action of HCN1 channels on
neural activity, both physiological and pathological patterns of
neuronal activity regulate the expression of HCN1. Stimuli that
induce long-term potentiation or long-term depression produce,
respectively, an upregulation (Fan et al., 2005) or downregulation
(Brager and Johnston, 2007) of Ih and HCN1 expression,
providing a homeostatic scaling mechanism that offsets
changes in synaptic efficacy by controlling dendritic excitability.
In contrast, maladaptive downregulation of HCN1 expression
following seizures enhances dendritic excitability and may
contribute to the development of temporal lobe epilepsy (Chen
et al., 2001a; Brewster et al., 2002, 2005; Shah et al., 2004;
Jung et al., 2007; Shin et al., 2008). These observations suggest
that powerful regulatory mechanisms must govern the ongoing
expression, function and localization of HCN channels in the
brain.
One widespread mechanism for regulating channel expres-
sion, function, and trafficking is through the association of the
pore-forming channel subunits with auxiliary subunits (Yu
et al., 2005). Auxiliary subunits for HCN channels could provide
a molecular mechanism for their activity-dependent regulation
and might explain why the properties of native Ih in neurons differ
from the properties of Ih formed by recombinant HCN subunits in
heterologous cells (e.g., Pedarzani and Storm, 1995; Magee,
1998; Gasparini and DiFrancesco, 1999; Santoro et al., 2000;
Franz et al., 2000; Chen et al., 2001b). Such subunits could
also help regulate the subcellular trafficking of the HCN chan-
nels. However, despite their potential importance, the existence
and function of HCN channel auxiliary subunits in the brain
remain poorly understood.
We previously used a yeast two-hybrid screen to identify
potential molecular partners of HCN1 and isolated a brain-
specific68 kD cytoplasmic protein, TRIP8b, that binds strongly
to HCN channels and is tightly colocalized with HCN1 in the
distal dendrites of neocortical and hippocampal pyramidal
neurons (Santoro et al., 2004). An analysis of cDNA isolates
reveals that the single TRIP8b gene is subject to extensive alter-
native splicing that affects the extreme N terminus of the protein
(Santoro et al., 2004). Thus, the TRIP8b gene encodes a family of
N-terminal splice variants that differ in their initial 7–112 amino
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isoforms. The TRIP8b splice variant that we previously charac-
terized exerts a powerful effect on HCN channel trafficking.
Overexpression of this splice variant in either heterologous
expression systems or cultured hippocampal pyramidal neurons
causes a dramatic, almost complete downregulation of surface
expression of HCN1 or HCN2 (Santoro et al., 2004).
Here, we document the presence in the brain of at least nine
alternatively spliced TRIP8b isoforms and show that different
isoforms have differential effects on HCN1 surface expression.
Importantly, one isoform leads to a marked upregulation of
HCN1 surface expression and Ih density in heterologous cells,
cultured hippocampal neurons, and CA1 pyramidal neurons in
the intact brain. Moreover, all TRIP8b isoforms examined exert
an inhibitory effect on HCN1 gating, shifting activation to more
negative voltages and slowing the rate of channel opening.
These results provide strong evidence that TRIP8b is an auxiliary
subunit of HCN1 channels ideally poised to mediate the dynamic
modulation of channel expression and function in discrete
regions of the brain.
RESULTS
Multiple Splice Variants of TRIP8b Are Expressed
in the Mouse Brain
As we previously reported, a comparison of the various GenBank
entries for TRIP8b orthologs suggests that the N-terminal
domain of this protein undergoes alternative splicing (Santoro
et al., 2004). To address the nature and extent of this diversity,
we performed an extensive reverse transcription-polymerase
chain reaction (RT-PCR) analysis of mRNA isolated from mouse
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Figure 1. Different TRIP8b Splice Isoforms Differ-
entially Regulate HCN1 Current Density
(A) Schematic representation of exons comprising the
open reading frame of TRIP8b. Exons 1a through 4 are
variably spliced. Arrows show locations and identity of
putative adaptin-binding consensus sequences. Tetratri-
copeptide repeats (TPR) shown as red rectangles.
(B) Two microelectrode voltage-clamp current traces from
Xenopus oocytes coinjected with cRNA encoding HCN1
together with GFP (control) or one of six TRIP8b splice
isoforms (labeled). Currents were elicited by a 3-s voltage
steps from a holding potential of30 mV to a range of test
potentials between +5 and 95 mV in increments of 10
mV, followed by a depolarizing step to 0 mV. Middle row
of traces show currents for HCN1 coexpressed with
TRIP8b(1b-2), TRIP8b(1b-2-4), and TRIP8b(1a) currents
at an expanded current scale (note scale bars). HCN1
plus GFP traces on top and bottom rows are identical to
aid in comparisons.
brain, using TRIP8b exon-specific primers.
Such analysis revealed the existence of nine
different splice variants of TRIP8b (Figure 1A;
see Figure S1 available online; Table 1). All vari-
ants include one of two alternative start codons,
each encoded in a separate exon (exons 1a and
1b), followed by different combinations of the
three subsequent exons (exons 2, 3, and 4). No variations are
found in the ensuing exons (exons 5–16), which encode the
bulk of the protein. As we previously reported, the C-terminal
half of TRIP8b (encoded by exons 10–16) contains six tetratrico-
peptide repeats (TPR), which constitute a conserved protein-
protein binding motif (Blatch and Lassle, 1999) that interacts
with the C-terminal ‘‘SNL’’ tripeptide sequence in HCN1, 2,
and 4 (Santoro et al., 2004; see Figure S1). Given the large inter-
vening distance (over 50 kb) between the end of exon 1a and the
start of exon 1b, two alternative promoters may drive expression
of the TRIP8b gene.
To determine the relative expression levels of individual
TRIP8b isoforms, we performed quantitative real-time PCR anal-
ysis on mouse brain mRNA, using primers spanning specific
exon-exon boundaries (see Experimental Procedures; Table
S1). The abundance of each of the splice forms was determined
as a percentage of total TRIP8b mRNA, the latter measured
using primer pairs that define amplicons within the constant
domain (exons 5–16). Our results indicate that TRIP8b(1a-4) is
the predominant TRIP8b mRNA species in the brain, accounting
for 30%–40% of total TRIP8b mRNA. TRIP8b(1b-2), the splice
variant described in our original study, accounts for10%–15%
of total brain TRIP8b mRNA. The second most abundant species
is TRIP8b(1a), representing 25%–30% of total TRIP8b mRNA.
Although it is not possible to draw a direct inference as to the
relative levels of protein expression of the different TRIP8b iso-
forms from the mRNA data, western blot analysis of brain tissue
using an antibody that recognizes all splice variants reveals two
prominent bands (Figure S2). Consistent with the results from the
quantitative PCR analysis, the most abundant TRIP8b protein
species comigrates with TRIP8b(1a-4), whereas the secondNeuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc. 803
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HCN1 Regulation by TRIP8b Splice VariantsTRIP8b protein species comigrates with TRIP8b(1a). The relative
abundance of all 9 TRIP8b splice forms determined by real-time
PCR analysis is presented in Table 1, along with a summary of
the effects of the major TRIP8b isoforms on HCN1 expression
and gating, which we present in detail below.
Alternative Splice Forms of TRIP8b Differentially
Regulate HCN1 Channel Expression
Sequence analysis reveals the presence of consensus protein
trafficking motifs in distinct TRIP8b exons, suggesting that the
various isoforms may exert specific effects on HCN1 trafficking
and surface expression (Figure S1). Indeed, we have previously
shown that TRIP8b(1b-2) induces the near-complete internaliza-
tion of HCN1 from the plasma membrane, resulting in an ac-
cumulation of channel protein in intracellular vesicles, a subset
of which can be identified as early endosomes (Santoro et al.,
2004). Consistent with this effect, TRIP8b(1b-2) contains a poten-
tial tyrosine-based trafficking motif (YXXØ) in exon 2. In addition,
dileucine-based ([DE]XXXL[LI]) trafficking motifs are found in
exons 4, 5, and 6. These signals are known to recruit distinct
sets of sorting machinery, including adaptor protein complexes
(AP-1, AP-2, and AP-3) that bind both clathrin and the YXXØ
and [DE]XXXL[LI] signaling sequences of cargo proteins (Bonifa-
cino and Traub, 2003).
Do different TRIP8b isoforms have distinct effects on HCN1
expression? To address this question, we coinjected cRNA en-
coding HCN1 with cRNA encoding each of six TRIP8b splice
variants into Xenopus oocytes and performed two-microelec-
trode voltage-clamp analysis of HCN1 current density. Maximal
tail current amplitude, as determined by a fit of the Boltzmann
equation to tail current activation curves, was dramatically
affected by five of the six alternative splice forms. As described
previously, TRIP8b(1b-2) essentially abolishes Ih current expres-
sion, reducing it to undetectable levels (>100-fold reduction;
Table 1. Relative Abundance of TRIP8b Splice Variants
Expressed in Mouse Brain and Effects of Six Major Variants
on HCN1 Channel Expression and Gating
TRIP8b Isoform
Effect on HCN1
Gating (DV1/2)
Effect on HCN1
Expression
% TRIP8b
mRNA
1a 13.4 mV 10-fold reduction 25%–30%
1a-2 9.3 mV no effect <10%
1a-2-3-4 TBD TBD <1%
1a-2-4 9.7 mV 5-fold increase <10%
1a-3-4 TBD TBD <5%
1a-4 11.6 mV 6-fold increase 30%–40%
1b-2 10.7 mV >100-fold reduction 10%–15%
1b-2-3-4 TBD TBD <1%
1b-2-4 14.7 mV >50-fold reduction 10%–15%
Splice form mRNA abundance was assessed by quantitative real-time
PCR analysis as a percentage of total TRIP8b mRNA. The indicated range
of values describes the variability observed between different mRNA/
cDNA preparations. DV1/2 values refer to the difference in the midpoint
of activation observed between HCN1 channels expressed with and
without the indicated TRIP8b splice variant (see Figure 4 and text).
TBD, to be determined.804 Neuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc.Figures 1B and 2). We now find that TRIP8b(1b-2-4) produces
a similarly dramatic reduction in Ih. TRIP8b(1a) also decreases
expression of HCN1, although the reduction in current density
is 10-fold, significantly less than the effect of TRIP8b(1b-2) or
TRIP8b(1b-2-4). In contrast, TRIP8b(1a-2) has no effect on Ih
levels. Strikingly, TRIP8b(1a-4) and TRIP8b(1a-2-4) produce up
to a 6-fold increase in Ih current density (Figures 1B and 2).
Both the downregulation and upregulation of HCN1 currents
represent specific effects since current levels expressed by
a variety of other channels, including CNGA1 (a channel closely
related to the HCN channels), KAT1 and Kv1.2, are largely unaf-
fected by coexpression with the TRIP8b isoforms (Santoro et al.,
2004; Figure S3). The only significant effect seen with any of the
TRIP8b isoforms on channels other than HCN1 was a very small
(15%) increase in Kv1.2 current amplitude upon coexpression
with TRIP8b(1a-4).
The upregulation or downregulation of Ih density produced by
these newly characterized TRIP8b isoforms appear to be caused
largely by changes in channel surface expression, similar to our
previous finding that TRIP8b(1b-2) promotes endocytosis of
surface HCN1 channels. Thus, coexpression in Xenopus oocytes
of TRIP8b(1a) with HCN1 channels tagged on their N terminus
with green fluorescence protein (GFP-HCN1) results in a dramatic
redistribution of the labeling to intracellular puncta (Figure S4),
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Figure 2. Effects ofWild-Type andMutant TRIP8b Isoforms onHCN1
Current Density
Population data showing maximal tail current amplitudes for HCN1 coex-
pressed with GFP (open bar), six wild-type TRIP8b isoforms (gray bars), or
three selected TRIP8b isoforms with mutations in putative adaptin-binding
sites (black bars) (see Experimental Procedures for details of tail current ampli-
tude measurements). Error bars show SEM. Mean current ± SEM (n = number
of experiments) for each pair of expressed constructs is as follows: HCN1 +
GFP, 1.12 ± 0.03 mA (n = 140); HCN1 + TRIP8b(1b-2), undetectable current
(<0.005 mA; n = 36); HCN1 + TRIP8b(1b-2-4), 0.02 ± 0.00 mA (n = 21); HCN1 +
TRIP8b(1a), 0.12 ± 0.01 mA (n = 29); HCN1 + TRIP8b(1a-2), 1.29 ± 0.13 mA (n =
16); HCN1 + TRIP8b(1a-4), 5.90 ± 0.33 mA (n = 30); HCN1 + TRIP8b(1a-2-4),
5.04 ± 0.27 mA (n = 35); HCN1 + TRIP8b(1b-2)Y38AL41A, 1.18 ± 0.06 mA
(n = 15); HCN1 + TRIP8b(1a-2)Y14AL17A, 3.08 ± 0.18 mA (n = 15); HCN1 +
TRIP8b(1a)L18AL19A, 4.02 ± 0.17 mA (n = 13).
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et al., 2004). In contrast, TRIP8b(1a-4) increases the level of GFP-
HCN1 associated with the dendritic plasma membrane when
overexpressed in neurons in vivo (see below, Figure 7).
Importance of Consensus Adaptor Protein Binding
Motifs in TRIP8b for HCN1 Channel Trafficking
To directly test whether the YXXØ motif in exon 2 is a critical
determinant of the effects of certain TRIP8b isoforms on HCN1
trafficking, we introduced point mutations that disrupt this
consensus site. Consistent with our hypothesis, the double point
mutation Y38A/L41A in the YXXØ motif blocks the ability of
TRIP8b(1b-2) to downregulate Ih (Figure 2). Interestingly, the
same double point mutation in the background of TRIP8b(1a-2)
causes this isoform, which normally has no effect on channel
surface expression, to increase Ih current density 3-fold above
baseline levels (Figure 2). This suggests that the lack of effect of
wild-type TRIP8b(1a-2) on Ih levels may result from opposing
influences of distinct sequences to enhance HCN1 expression
and promote channel internalization.
In addition to the YXXØ motif in exon 2, other regions of
TRIP8b must also contribute to the downregulation of channel
expression because TRIP8b(1a), which lacks exon 2, also exerts
a strong inhibitory effect on HCN1 surface expression. We there-
fore explored the role of the two dileucine-based trafficking
motifs ([DE]XXXL[LI]) present within the invariant region of
TRIP8b (exons 5,6; Figures 1A and S1). Mutation of the first dileu-
cine motif (ESRPLL to ESRPAA; TRIP8b(1a)L18A/L19A) abolished
the ability of TRIP8b(1a) to downregulate Ih density and also
revealed a latent stimulatory effect of this isoform, which now
increased current levels 4-fold above baseline (Figure 2). In
A
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Figure 3. Association of TRIP8b with HCN1 and Adaptor Protein 2
(AP-2) in Forebrain
Western blots of total protein from solubilized membrane extracts of adult
mouse forebrain cortex (input lane) or proteins immunoprecipitated using pre-
immune serum (pre-imm lane), an anti-TRIP8b antibody (TRIP8b lane), or an
anti-HCN1 antibody (HCN1 lane). Gels were probed with antibodies to
HCN1 (A), adaptin b (B), adaptin g (C), or adaptin a (D). In (A), input sample con-
tained 50% of extract subjected to immunoprecipitation reactions. Note that
TRIP8b antibody coprecipitates a large fraction of total HCN1. In (B), input
sample contained 10% of extract subjected to immunoprecipitation reactions,
and in (C) and (D) it contained 5% of extract. TRIP8b antibody coprecipitates
adaptin b (weak signal) and adaptin a, but not adaptin g. Anti-HCN1 antibody
coprecipitates adaptin a. Molecular weight marker positions are indicated to
the right of each panel.contrast, mutation of the second motif (DGSDLI to DGSDAA;
TRIP8b(1a)L87A/I88A) had no effect on the ability of TRIP8b(1a)
to downregulate Ih (data not shown). A quadruple mutant that
disrupted both dileucine motifs (L18A/L19A/L87A/L88A)
behaved similarly to the L18A/L19A mutant (data not shown).
HCN1, TRIP8b, and AP-2 Form a Macromolecular
Complex In Vivo
The finding that the YXXL motif in exon 2 and EXXXLL motif in
exon 5 are critical for the ability of distinct isoforms of TRIP8b
to reduce HCN1 surface expression strongly supports a model
in which TRIP8b acts as a bridge protein, recruiting AP-2 adap-
tors to TRIP8b/HCN1 channel complexes that enable the forma-
tion of clathrin coated pits and subsequent channel endocytosis.
Consistent with this hypothesis, we find that HCN1 and TRIP8b
are indeed tightly associated in the brain. Thus, an anti-TRIP8b
antibody coimmunoprecipitates up to 50% of HCN1 present in
solubilized membrane protein extracts of mouse forebrain cortex
(Figure 3A). Given the limits of the precipitation reaction, these
results suggest that the majority of HCN1 protein is normally
associated with TRIP8b in the forebrain cortex.
Next, we examined whether AP trafficking proteins are, in fact,
associated with the HCN1/TRIP8b complexes. When the brain
proteins coimmunoprecipitated with anti-TRIP8b antibodies
were probed with antibodies directed to adaptin b (recognizing
the b subunit of both adaptor proteins AP-1 and AP-2), we de-
tected a weak but specific positive signal (Figure 3B). Further
probing of the complexes with antibodies directed to adaptin g
(the g subunit specific to AP-1) and adaptin a (the a subunit
specific to AP-2) revealed that the in vivo association with
TRIP8b was specific for AP-2, with no detectable levels of
AP-1 complexes (Figures 3C and 3D).
TRIP8b Inhibits HCN1 Channel Opening
Many auxiliary subunits alter channel gating in addition to regu-
lating trafficking. We speculated that the interaction of TRIP8b
with HCN1 might account for certain discrepancies between
the properties of native and heterologously expressed Ih. For
example, the voltage-dependent opening of native Ih in hippo-
campal CA1 neurons, which express mainly HCN1 and HCN2
subunits, occurs at significantly more negative potentials than
does that of recombinant heteromeric channels formed from
these same subunits (e.g., see Magee, 1998; Chen et al.,
2001b). Similarly, the efficacy of cAMP to facilitate the opening
of Ih in CA1 neurons (Pedarzani and Storm, 1995; Gasparini
and DiFrancesco, 1999; Franz et al., 2000) is considerably less
than that seen with the recombinant HCN1/HCN2 heteromers
(Chen et al., 2001b).
To address the possibility that TRIP8b alters HCN1 channel
gating, we compared the voltage dependence of channel activa-
tion using a two-microelectrode voltage clamp of intact oocytes
when HCN1 was coexpressed with GFP or with different TRIP8b
isoforms. In contrast to the differential effects of the TRIP8b iso-
forms on HCN1 trafficking, all splice variants tested exert a
similar inhibitory effect on HCN1 opening, shifting the voltage
at which HCN1 channels are half-activated (V1/2) by 10 mV
toward more negative potentials (Figure 4C; Table 1). Although
the near complete downregulation of HCN1 current withNeuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc. 805
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Inhibits the Opening of HCN1 Channels
(A) Two microelectrode voltage-clamp current
traces from oocytes coinjected with cRNA encod-
ing HCN1 and GFP. Three second voltage steps
applied from a holding potential of 30 mV to
a range of test potentials between +5 mV and
105 mV in increments of 10 mV, followed by a
depolarizing step to 0 mV.
(B) Two microelectrode voltage-clamp current
records from oocytes coinjected with cRNA en-
coding HCN1 and TRIP8b(1a-2). Protocol as
above.
(C) Normalized tail current activation curves
with fits of Boltzmann equation for HCN1 ex-
pressed with GFP (squares), TRIP8b(1a-2) (cir-
cles), or TRIP8b(1a-4) (triangles). Mean values for
V1/2 ± SEM (n) are as follows: HCN1 + GFP,
61.7 ± 0.2 mV (n = 140); HCN1 + TRIP8b(1a-4),
73.3 ± 0.6 mV (n = 16); HCN1 + TRIP8b(1a-2),
71.0 ± 0.5 mV (n = 16) (p < 104; ANOVA, Tukey
HSD test). Note that there is no significant differ-
ence in the midpoint of activation of HCN1 chan-
nels in the presence or absence of GFP (HCN1
alone, V1/2 = 62.8 ± 0.5 mV, n = 19).
(D) Time constants of current activation during
hyperpolarizing steps to indicated voltages and
time constant of deactivation during step to 0 mV
(right axis). Symbols as in (C).TRIP8b(1b-2) prevented us from examining its effects on channel
gating, the TRIP8b(1b-2)Y38A/L41A exon 2 mutant, which does
not downregulate HCN1, also exerts a hyperpolarizing shift in
HCN1 gating. Furthermore, all TRIP8b isoforms examined sig-
nificantly slow the kinetics of channel opening and speed the
kinetics of channel closing (Figure 4D). The mean V1/2 ± SEM
values for HCN1 coexpressed with either GFP (as a control) or
a TRIP8b splice variant were as follows: HCN1 + GFP, 61.7 ±
0.2 mV (n = 140); HCN1 + TRIP8b(1a-4),73.3 ± 0.6 mV (n = 16);
HCN1 + TRIP8b(1a-2), 71.0 ± 0.5 mV (n = 16); HCN1 +
TRIP8b(1b-2)Y38A/L41A, 72.4 ± 0.5 mV (n = 15); HCN1 +
TRIP8b(1b-2-4),76.4 ± 0.7 mV (n = 9); HCN1 + TRIP8b(1a-2-4),
71.4 ± 0.3 mV (n = 35); HCN1 + TRIP8b(1a), 75.1 ± 0.6 mV
(n = 29).
Intriguingly, the changes in HCN1 channel gating observed
with TRIP8b are the opposite of the effects of cAMP, which shifts
the V1/2 to more positive potentials, speeds the kinetics of
channel activation and slows the time course of deactivation.
Previous studies from our laboratory indicate that basal levels
of cAMP in oocytes are sufficient to facilitate the opening of
HCN channels to more positive potentials (Chen et al., 2001b;
Wang et al., 2002). Thus, TRIP8b might inhibit channel opening
by antagonizing the facilitatory action of endogenous levels of
cAMP.
To address this possibility, we examined the effects of TRIP8b
on the gating of two mutant HCN1 channels in which a conserved
arginine residue (R538) in the cyclic nucleotide binding domain
was mutated to either alanine (R538A) or glutamate (R538E).
These mutations have no effect on channel gating in the absence
of cAMP but cause a 20-fold (R538A) or 2000-fold (R538E)
decrease in the affinity of the channel for cAMP, preventing basal
levels of cAMP from enhancing channel opening (Chen et al.,806 Neuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc.2001b; Zhou and Siegelbaum, 2007). Thus, if TRIP8b inhibits
HCN1 gating by antagonizing the facilitatory action of basal
levels of cAMP, then we expect that the gating of the two mutant
channels should be unaffected by the presence of TRIP8b.
Under the conditions of our experiments, we find that the
voltage-dependent opening of HCN1R538A and HCN1R538E in
the absence of TRIP8b is shifted to more negative potentials
by 15 mV relative to wild-type HCN1 (Figure 5A), reflecting
the blockade of the normal facilitatory effect of basal cAMP
(note, this 15 mV shift is greater than the 7 mV shift reported
previously by Chen et al. [2001b], due to differences in extracel-
lular recording solutions; see Experimental Procedures). Impor-
tantly, the two mutant channels show no change in gating
upon coexpression of TRIP8b (Figure 5A). The simplest interpre-
tation of these results is that TRIP8b does indeed inhibit HCN1
gating by antagonizing the actions of basal levels of cAMP.
However, these findings do not rule out a more complex scheme,
in which TRIP8b inhibits channel gating at a second site that is
independent of cAMP action.
To test more directly the idea that TRIP8b inhibits the action of
cAMP, we examined the effects on HCN1 gating when cAMP
was applied to the internal surface of the channels in cell-free
patches in the absence or presence of TRIP8b. According to
the cAMP hypothesis, TRIP8b should have no effect on the
gating of HCN1 in the cell-free patches in the absence of
cAMP, but should reduce the facilitatory effect of bath-applied
cAMP. In accord with the first prediction, the V1/2 of HCN1
channel activation in the absence of cAMP is identical in the
absence or presence of TRIP8b(1a-4). However, contrary to
the second prediction, TRIP8b coexpression does not alter the
response of the channel to cAMP in the cell-free patches.
Thus, the maximal shift in the V1/2 of channel activation in
Neuron
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Figure 5. Effects of TRIP8b on the Modulation of HCN1 Channel
Gating by cAMP in Intact Oocytes and Cell-Free Inside-Out Patches
(A) In intact oocytes, TRIP8b(1a-4) coexpression shifts the gating of wild-type
HCN1 to more negative voltages but does not alter gating of two HCN1 mutants
with decreased affinity for cAMP. Oocytes were coinjected with cRNAs encod-
ing wild-type or mutant HCN1 and either GFP or TRIP8b(1a-4). Symbols plot
mean V1/2 values in absence (filled symbols) or presence (open symbols) of
TRIP8b(1a-4). Error bars show SEM. Mean values for V1/2 ± SEM (n) are as
follows: HCN1 + GFP,61.7 ± 0.2 mV (n = 140); HCN1 + TRIP8b(1a-4),73.3 ±
0.6 mV (n = 16); HCN1R538A + GFP, 76.2 ± 0.3 mV (n = 27); HCN1R538A +
TRIP8b(1a-4), 75.3 ± 0.3 (n = 27); HCN1R538E + GFP, 76.8 ± 0.5 mV
(n = 18); HCN1R538E + TRIP8b(1a-4), 78.3 ± 0.5 mV (n = 21).
(B) In cell-free patches, channels from oocytes expressing a TRIP8b(1a-4)-
HCN1 fusion protein show a reduced response to cAMP compared to channels
from oocytes expressing either a GFP-HCN1 fusion protein or coexpressing
GFP-HCN1 with TRIP8b(1a-4). Patches were held at30 mV and 3 s hyperpo-
larizing steps applied to a series of test potentials from40 mV to130 mV. Tail
currents were measured upon return to 30 mV. Open symbols show V1/2 in
absence of cAMP and filled symbols show V1/2 in presence of a saturating
concentration of cAMP (10 mM). Error bars show SEM. Mean ± SEM (n) values
for V1/2 in the absence of cAMP are as follows: GFP-HCN1, 92.1 ± 1.4 mV
(n = 6); GFP-HCN1 + TRIP8b(1a-4), 93.8 ± 1.0 mV (n = 8); TRIP8b(1a-4)-
HCN1,95.5 ± 1.3 mV (n = 7). There is no significant difference in the V1/2 values
of the three populations in the absence of cAMP (p > 0.15; ANOVA, Tukey HSD
test). There is also no significant difference between the V1/2 values of the
GFP-HCN1 fusion protein with or without TRIP8b(1a-4) coexpression in the
presence of cAMP. Note that TRIP8b(1a-4) also caused no change in the V1/2
when coexpressed with wild-type HCN1, either in the absence (p > 0.9,
ANOVA, Tukey HSD test) or presence of cAMP (p > 0.8, ANOVA, Tukey HSD
test; HCN1, n = 12, HCN1 + TRIP8b(1a-4), n = 14).
(C) Effect of 10 mM cAMP measured as difference in V1/2 (DV1/2) in the presence
and absence of cAMP. Bars show mean DV1/2 values; error bars show SEM.
Mean DV1/2 ± SEM values are as follows: GFP-HCN1, 7.4 ± 0.7 mV (n = 6);
GFP-HCN1 + TRIP8b(1a-4), 7.7 ± 0.2 mV (n = 8); TRIP8b(1a-4)-HCN1, 5.3 ±
0.2 mV (n = 7). The DV1/2 for TRIP8b(1a-4)-HCN1 was significantly less than
that for GFP-HCN1 or for GFP-HCN1 coexpressed with TRIP8b(1a-4) (p <
0.003; ANOVA, Tukey HSD test).response to a saturating concentration (10 mM) of cAMP (7–8 mV)
is not altered when HCN1 is coexpressed with TRIP8b (Figure 5B;
note, this 7–8 mV shift is larger than the 3–5 mV shift previously
reported by Chen et al. [2001b] because of the inclusion of Ca2+
in our patch pipette solution; see Experimental Procedures). This
indicates that TRIP8b does not alter cAMP efficacy. Moreover,
TRIP8b appears to have no effect on the affinity of the channel
for cAMP, as the voltage shift in response to a subsaturating
concentration of cAMP that is approximately equal to the EC50
(100 nM) is also unchanged by TRIP8b coexpression (data not
shown).
One possible reason why TRIP8b(1a-4) might inhibit the action
of cAMP in intact oocytes but fail to antagonize the action of cAMP
in inside-out patches is that TRIP8b dissociates from HCN1 upon
patch excision. To test this idea, we constructed a fusion protein
in which the C terminus of TRIP8b(1a-4) was attached to the
N terminus of HCN1. The TRIP8b(1a-4)-HCN1 fusion protein
forms functional hyperpolarization-activated channels whose
V1/2 in intact oocytes (81.1 ± 0.4 mV, n = 10) is 15 mV more
negative than the V1/2 of channels formed by a GFP-HCN1 fusion
protein (64.5 ± 0.2 mV, n = 14). This15 mV shift is comparable
to the shift we observe when TRIP8b(1a-4) and HCN1 are coex-
pressed as separate proteins (see Figures 4 and 5A and Table
1), indicating that TRIP8b is able to exert its full inhibitory effect
as a fusion protein.
In cell-free patches, GFP-HCN1 and TRIP8b(1a-4)-HCN1
show a similar voltage-dependence of gating in the absence
of cAMP, with no significant difference in their V1/2 values
(Figure 5B). However, the maximal shift in the V1/2 of the
TRIP8b(1a-4)-HCN1 fusion protein in response to a saturating
concentration of cAMP is now significantly reduced compared
to the maximal response of GFP-HCN1 (Figures 5B and 5C).
Such results support the view that TRIP8b does indeed antago-
nize the ability of cAMP to shift HCN1 channel opening to more
positive potentials and that the interaction of TRIP8b with
HCN1 may be weakened following patch excision.
TRIP8b(1a-4) Enhances Endogenous Ih Current Density
and Inhibits Its Gating in Hippocampal Neurons In Vitro
If TRIP8b is indeed an HCN channel auxiliary subunit, we would
expect that it should alter the gating and exert isoform-specific
effects on the expression of native Ih in neurons, similar to its
effects on HCN1 in heterologous systems. We previously re-
ported that TRIP8b(1b-2) drastically reduces endogenous Ih
current levels when transfected into hippocampal pyramidal
neurons in dissociated cell culture (Santoro et al., 2004). Here,
we asked whether TRIP8b(1a-4) can increase Ih current density
and shift activation to more negative voltages in cultured hippo-
campal neurons, similar to its effects in Xenopus oocytes.
Whole-cell recordings were obtained from neurons infected
with a lentivirus expressing either GFP or TRIP8b(1a-4) tagged
on its N terminus with GFP. We found that TRIP8b(1a-4)
produces an 2.5-fold increase in Ih current density, an 8.5
mV negative shift in the midpoint of Ih activation, and an increase
in the time constant of Ih activation at all voltages tested
(Figure 6), effects similar to those observed in the oocytes.
When combined with our previous results that Ih in hippocampal
neurons is downregulated by TRIP8b(1b-2), these data verify theNeuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc. 807
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Figure 6. Overexpression of TRIP8b(1a-4)
in Cultured Hippocampal Neurons Alters
the Expression and Gating Properties of
Endogenous Ih
(A) Ih current traces from a whole-cell voltage-
clamp recording of a cultured hippocampal pyra-
midal neuron overexpressing GFP-TRIP8b(1a-4).
Currents were elicited by a series of 3 s hyperpola-
rizing voltage steps from a holding potential of
65 mV to a range of test potentials between
20 mV and 120 mV in increments of 10 mV, fol-
lowed by a step to100 mV. Every second trace is
displayed.
(B) TRIP8b(1a-4) enhances maximal Ih tail current
density (normalized by capacitance). Mean den-
sities ± SEM (n) are as follows: GFP, 0.99 ± 0.17
pA/pF (n = 8); GFP-TRIP8b(1a-4), 2.44 ± 0.2 pA/
pF (n = 6), p < 0.001 (t test).
(C) TRIP8b(1a-4) shifts native Ih activation to more
negative potentials. Tail current activation curves
fit by Boltzmann equation for group data. Error
bars show SEM. Mean V1/2 ± SEM (n) are as follows:
GFP, 63.7 ± 1.4 mV (n = 8); GFP-TRIP8b(1a-4),
72.12 ± 0.7 mV (n = 6); p < 0.001, t test.
(D) TRIP8b(1a-4) slows the time course of Ih activa-
tion. Single exponential time constants plotted as
function of voltage during the hyperpolarizing
steps. Symbols as in (C).ability of distinct TRIP8b isoforms to either upregulate or down-
regulate the expression of Ih and to produce an inhibitory effect
on the opening of native HCN channels in neurons.
Effects of TRIP8b(1a-4) and TRIP8b(1b-2)
Overexpression in Hippocampal CA1 Pyramidal
Neurons In Vivo
To determine whether TRIP8b isoforms can differentially regu-
late HCN1 expression in neurons in the intact hippocampus,
we injected lentivirus expressing GFP-TRIP8b(1a-4), GFP-
TRIP8b(1b-2), or GFP alone into the CA1 region of adult mice
in vivo. This method achieves stable protein expression that
persists for several weeks. Surprisingly, none of the TRIP8b
constructs alter the expression or distribution of endogenous
HCN1 channels in wild-type mice, as assayed by HCN1 immuno-
fluorescence, even 3–4 weeks after viral injection and despite the
strong expression of the lentivirus-driven TRIP8b proteins (data
not shown).
We reasoned that virally expressed TRIP8b may fail to regulate
HCN1 channels in adult brain if the channels preexist in stable
complexes with endogenous TRIP8b. We therefore examined
the effects of TRIP8b using coinjection of independent lentivirus
vectors that express a GFP-HCN1 fusion protein and HA-tagged
TRIP8b in the background of HCN1 knockout mice (Nolan et al.,
2003), to ensure that both HCN1 and TRIP8b proteins would be
synthesized simultaneously. Indeed, this approach reveals
dramatic, isoform-dependent effects of TRIP8b on the expres-
sion and trafficking of the GFP-HCN1 fusion protein (Figure 7).
When GFP-HCN1 is coexpressed with the soluble fluorescent
protein dsRed2 (as a control), we observe a high level of expres-
sion of channels that are efficiently targeted to the distal portion
of the apical dendrites, identical to the distribution of endoge-808 Neuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc.nous HCN1 protein normally observed in wild-type mice (e.g.,
Santoro et al., 1997, 2004). Coexpression of GFP-HCN1 with
TRIP8b(1a-4)-HA strongly enhances the overall expression of
the GFP-HCN1 fusion construct, with intense GFP-HCN1
labeling of apical dendrites as well as enhanced labeling of basal
dendrites and soma (Figure 7). The enhanced railroad-track
pattern of the GFP-HCN1 signal in the CA1 apical dendrites is
strongly suggestive of increased HCN1 channel expression in
the dendritic surface membrane viewed in a confocal cross-
section along the longitudinal axis of the dendrite (Figure 7,
bottom right). In stark contrast, coexpression of GFP-HCN1
with TRIP8b(1b-2)-HA results in the sequestering of the GFP-
HCN1 channel into intracellular puncta, visible both at the level
of the soma and apical dendrites (Figure 7, middle right), consis-
tent with our previous results in heterologous cells (Santoro et al.,
2004). Thus, TRIP8b exerts similar isoform-dependent actions on
Ih and HCN1 channel expression in Xenopus oocytes, isolated
hippocampal neurons in vitro, and CA1 pyramidal neurons in vivo.
DISCUSSION
This study demonstrates that TRIP8b is an auxiliary subunit that
associates with HCN1 channels in the brain, thus regulating
channel surface expression and gating. We identify nine different
TRIP8b splice variants in brain and demonstrate the differential
effects of six of these isoforms on HCN1 surface expression.
TRIP8b(1b-2) and TRIP8b(1b-2-4) cause a near complete loss of
surface expression; TRIP8b(1a) causes a smaller but still marked
10-fold decrease in HCN1 current density; TRIP8b(1a-2)
has no effect on surface expression; and TRIP8b(1a-4) and
TRIP8b(1a-2-4) cause up to an 6-fold increase in surface
expression. In distinction to the differential effects of TRIP8b
Neuron
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Hippocampal CA1 Neurons In Vivo Affects the Intracellular Distribu-
tion of HCN1
Lentiviruses driving expression of a GFP-HCN1 fusion protein were stereotax-
ically injected in vivo in the CA1 region of the hippocampus of HCN1 knockout
mice, along with a second lentivirus driving expression of dsRed2 (top),
TRIP8b(1b-2)-HA (middle), or TRIP8b(1a-4)-HA (bottom). Confocal images
from thin, fixed hippocampal slices show direct GFP fluorescence, as a marker
of injected GFP-HCN1 channel protein expression and localization. so,
stratum oriens; sp, stratumpyramidale; sr, stratum radiatum; slm, stratum lacu-
nosum-moleculare. Left, low-magnification images (scale bar, 100 mm). Right,
high-magnification images at the level of stratum radiatum (scale bar 20 mm).
Notice the railroad-track pattern of intense GFP-HCN1 signal upon coexpres-
sion with TRIP8b(1a-4) representing enhanced membrane signal in CA1 pyra-
midal neuron apical dendrites as observed in confocal optical cross-section.
Also note the appearance of intracellular puncta upon coexpression with
TRIP8b(1b-2). Representative images from the following total number of
experiments (n, number of independent injection sites): GFP-HCN1 + dsRed2,
n = 35 (12 animals); GFP-HCN1 + TRIP8b(1a-4)-HA, n = 16 (5 animals);
GFP-HCN1 + TRIP8b(1b-2)-HA, n = 6 (2 animals).isoforms on channel expression, all splice variants examined
exert a similar action to inhibit HCN1 channel gating, which
involves a shift in the voltage-dependence of channel opening
to more negative potentials, a slowing of the rate of activation
upon hyperpolarization, and a speeding of the rate of deactiva-
tion upon depolarization.
The isoform-specific effects of TRIP8b on channel surface
expression and the invariant inhibitory action on channel opening
are also observed with native Ih in cultured hippocampal pyra-
midal neurons. Moreover, TRIP8b isoforms also differentially
regulate surface expression of HCN1 in hippocampal CA1 pyra-
midal neurons in vivo. These results, together with the robust
biochemical association between HCN1 and TRIP8b in vivo
(Figure 3) and the tight colocalization of the two proteins in the
distal dendrites of cortical pyramidal neurons (Santoro et al.,
2004), strongly suggest that TRIP8b plays an important role in
the regulation of Ih in the brain.
Trafficking Motifs within TRIP8b
Specific sequences within the N terminus of the TRIP8b protein
mediate the inhibitory effects on HCN1 surface expression, most
likely by recruiting AP-2 adaptor complexes that promote
channel internalization through clathrin-mediated endocytosis
(Bonifacino and Traub, 2003). Our mutagenesis experiments
establish the role of the YXXL and EXXXLL consensus AP-
binding site motifs, present in exon 2 and exon 5, respectively,
in the action of distinct TRIP8b isoforms to decrease the surface
expression of HCN1 channels. This interpretation is supported
by the recent identification of AP-2 subunits and clathrin binding
to immobilized recombinant TRIP8b following affinity chroma-
tography of brain extracts (Popova et al., 2008). Interestingly,
the effects of the trafficking motifs present within specific
TRIP8b exons on HCN1 channel expression are not autonomous
but appear to be sensitive to neighboring protein sequence.
Thus, although TRIP8b(1a-2) contains the YXXL motif in exon 2,
this isoform has little effect on HCN1 expression levels. More-
over, whereas the EXXXLL motif in exon 5 is present in all TRIP8b
isoforms, this motif induces a downregulation of HCN1 current
density only in the background of TRIP8b(1a).
Although wehave not identified specific sequences thatmediate
the upregulation of HCN1 current density by TRIP8b(1a-4) and
TRIP8b(1a-2-4), upregulation may be a latent property of all
TRIP8b isoforms, rather than a specific effect of exon 4. Thus,
despite the presence of exon 4, TRIP8b(1b-2-4) causes a near-
complete reduction in surface expression, similar to the effect of
TRIP8b(1b-2). Moreover, TRIP8b(1a) carrying mutations in the
EXXXLL motif of exon 5 or TRIP8b(1a-2) carrying mutations in the
YXXL motif of exon 2 cause a significant increase in HCN1 current
density above baseline levels, despite the absence of exon 4.
Upregulation of current density by wild-type TRIP8b(1a-4),
TRIP8b(1a-2-4), and the mutated isoforms is likely to be caused
by an increase in HCN1 surface expression rather than an effect
on channel gating as all TRIP8b isoforms have an inhibitory effect
on channel opening. Moreover, in vivo expression of TRIP8b
(1a-4) produces a marked increase in the level of GFP-tagged
HCN1 protein associated with the dendritic plasma membrane
(Figure 7). Whether the positive effect of TRIP8b on HCN1
surface expression is due to increased protein translation,Neuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc. 809
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membrane remains to be determined.
Mechanism of the Effects of TRIP8b on HCN1 Gating
The facilitation of HCN channel opening by the direct binding of
cAMP provides the best known means of regulating HCN
channel function (Robinson and Siegelbaum, 2003; Craven and
Zagotta, 2006). In cell-free patches, submicromolar concentra-
tions of cAMP shift the gating of HCN channels to more positive
voltages. This high sensitivity of HCN channels to ligand enables
their opening in intact cells to be enhanced by low basal levels of
cAMP (Chen et al., 2001b; Wang et al., 2002). Our results
suggest that the inhibitory effects of TRIP8b on HCN1 channel
opening in intact cells may be due to an antagonism of these
facilitatory effects of basal levels of cAMP as we find that TRIP8b
does not alter the gating of mutant HCN1 channels (R538A or
R538E) that do not bind cAMP with high affinity. However, this
simple view is not supported by our finding that, in cell-free
patches, the response of HCN1 channels to direct application
of cAMP is unaffected by coexpression of TRIP8b. This negative
result may be due, in part, to the failure of TRIP8b to remain asso-
ciated with HCN1 channels in cell-free patches as a TRIP8b-
HCN1 fusion protein does exhibit a reduced response to cAMP.
In contrast to our findings with HCN1, a recent study demon-
strates that HCN2 channels in cell-free patches do show a
reduced response to cAMP when coexpressed with TRIP8b as
independent proteins (Zolles et al., 2009, this issue of Neuron).
This may indicate that HCN2 and TRIP8b form a more stable
complex than do HCN1 and TRIP8b. Nonetheless, our findings
with HCN1, and preliminary results with HCN2 (L.H., unpublished
data) indicate that the extent to which TRIP8b reduces the
maximal voltage shift produced by a saturating concentration
of cAMP in cell-free patches, either when TRIP8b is coexpressed
with HCN2 or fused to HCN1, is significantly less than the extent
to which TRIP8b shifts the voltage-dependent gating of either
HCN1 or HCN2 in intact cells. This quantitative discrepancy
between whole-cell and cell-free results may indicate that the
ability of TRIP8b to inhibit HCN channel opening, either by antag-
onizing the action of cAMP or through some other mechanism,
requires an intracellular factor that is lost upon patch excision.
Potential Roles of TRIP8b in Regulating HCN1
Expression and Function In Vivo
To date, our understanding of the mechanisms that modulate
HCN channel function in vivo is limited. The opposing effects
of different TRIP8b isoforms to upregulate or downregulate
levels of HCN1 expression provide an attractive molecular
mechanism to mediate the reported up- and downregulation of
Ih and HCN1 levels as a function of neural activity. For example,
in CA1 neurons, relatively weak patterns of neuronal activation
that induce long-term depression of excitatory synaptic trans-
mission downregulate Ih, producing a homeostatic enhancement
in dendritic integration and excitability (Brager and Johnston,
2007). In contrast, a very strong pattern of neuronal activity asso-
ciated with the induction of long-term potentiation upregulates
Ih, producing a homeostatic inhibitory effect on dendritic integra-
tion (Fan et al., 2005; Campanac et al., 2008). Slightly weaker
patterns of activity that induce a moderate amount of long-810 Neuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc.term potentiation lead to a downregulation of Ih, representing
a complementary excitatory effect to enhance dendritic integra-
tion (Wang et al., 2003; Campanac et al., 2008).
In entorhinal cortex and hippocampal CA1 pyramidal neurons,
sites of high TRIP8b expression, intense levels of neuronal
activity during seizures lead to a long-lasting downregulation of
Ih current density, which increases neuronal excitability and
may contribute to the development of epilepsy (Shah et al.,
2004; Shin et al., 2008). Interestingly, this latter effect on Ih is
independent of long-term changes in HCN protein levels. An
increase in the expression of TRIP8b splice variants that cause
HCN1 internalization could produce such a long-term downre-
gulation of Ih current density without altering total protein levels.
Recent findings indicate that dendrites are not only endowed
with the ability to initiate regulated, local mRNA translation but
also possess RNA splicing capability (Glanzer et al., 2005).
Thus, the hypothesis that neuronal activity might control the
alternative splicing of TRIP8b isoforms, potentially on a local
level, represents an intriguing area of investigation.
Changes in the relative mRNA or protein levels of individual
TRIP8b splice variants due to alterations in transcription, RNA
processing or translation provide a potential means for regu-
lating Ih on a relatively slow time scale, requiring minutes to hours
to manifest. However, it is also possible that TRIP8b might
mediate effects on a more rapid time scale due to changes in
protein phosphorylation. Activation of different protein kinases,
for example CaMKII or PKC, underlies the rapid, activity-depen-
dent modulation of Ih in hippocampal slices in response to
different patterns of neuronal activity (Fan et al., 2005; Brager
and Johnston, 2007). Based on sequence analysis, several
potential serine/threonine phosphorylation sites are present
on the different TRIP8b splice variants. These sites could modu-
late the binding of TRIP8b to trafficking factors or to HCN1 itself,
thus providing a mechanism to achieve rapid decreases (or
increases) in net Ih density.
In hippocampal CA1 neurons Ih is likely to be comprised of
both HCN1 and HCN2 (Santoro et al., 2000). Although here
we focus on the effects of TRIP8b on HCN1, we previously
found that TRIP8b(1b-2) produces a potent downregulation
in the surface expression of HCN2, which also contains the
C-terminal SNL tripeptide-TRIP8b binding site (Santoro et al.,
2004). As discussed above, a recent study (Zolles et al., 2009)
and our preliminary results (L.H., unpublished data) indicate
that the gating of HCN2 is regulated by TRIP8b in a manner
similar to that of HCN1. However, our preliminary results and
those of Zolles et al. (2009) indicate that TRIP8b isoforms may
produce differential effects on the surface expression of
HCN2 compared to HCN1. Interestingly, discordant changes
in the expression of HCN1 versus HCN2 subunits as a result
of neuronal activity have been described in a number of para-
digms (e.g., Brewster et al., 2002, 2005; Fan et al., 2005; Jung
et al., 2007; Shin et al., 2008). In particular, following kainate-
induced status epilepticus, there is a specific downregulation
and redistribution of HCN1 protein from the distal dendrites to
the soma of hippocampal pyramidal neurons; in contrast, the
level and distribution of HCN2 subunits are unaltered (Shin
et al., 2008). Furthermore, there is a decrease in the amount
of TRIP8b associated with HCN1, but not HCN2. Differences
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subunits with TRIP8b isoforms could thus provide the molecular
means to achieve such subunit-specific modulation.
In addition to regulating HCN1 expression, the strong influence
of TRIP8b on HCN1 gating in intact cells is likely to modulate the
behavior of Ih in vivo. Interestingly, we find that the voltage-
dependence of Ih in cultured dissociated hippocampal neurons
from newborn animals, which express low levels of TRIP8b, is
significantly more positive than that of Ih in CA1 neurons from
adult mice, where high endogenous levels of TRIP8b are present
(R.A.P., unpublished data). We find here that overexpression of
TRIP8b in the cultured neurons shifts the voltage-dependence
of Ih activation to more negative potentials, more closely match-
ing the voltage-dependence of Ih in CA1 neurons from adults. Of
further interest, the activation of Ih in CA1 distal apical dendrites is
shifted by 6 mV to more negative voltages than those required
to activate Ih in more proximal regions of the dendrite (Magee,
1998), an effect that might be explained by a more prominent
association of TRIP8b with HCN1 channels in the distal dendrites,
where TRIP8b and HCN1 colocalization is tightest (Santoro et al.,
2004). The high levels of TRIP8b in neurons may also explain why
the effect of cAMP on native Ih in CA1 pyramidal neurons (Pedar-
zani and Storm, 1995; Gasparini and DiFrancesco, 1999; Franz
et al., 2000) is much less than the effect of cAMP on HCN1/
HCN2 heteromers in heterologous cells (Chen et al., 2001b).
In conclusion, our findings strongly suggest that TRIP8b is
a critical factor in regulating the gating and trafficking of HCN
channel subunits in the brain to dynamically control neuronal
activity. Moreover, such TRIP8b/HCN channel interactions are
likely to have important consequences for the modulation of
neural function both in physiological states as well as in disease.
EXPERIMENTAL PROCEDURES
Plasmids, Molecular Biology, and Heterologous Expression
Oocyte Expression
All constructs were cloned into plasmids pGHE or pGH19, linearized, and tran-
scribed into cRNA using T7 polymerase (MessageMachine, Ambion) as
described (Santoro et al., 2004). TRIP8b cDNA constructs were generated
by reverse transcription-PCR (RT-PCR) from polyA+ RNA from adult mouse
brain (see below). Site-directed mutagenesis was performed using Quick-
Change Mutagenesis kit (Stratagene) and polymerase chain reaction (PCR)
cloning. Oocytes were injected with 50 nl of cRNA solution each, at a constant
concentration of 0.5 mg/ml for HCN channel constructs and 0.2 mg/ml for GFP
or TRIP8b constructs.
Lentivirus Expression
The lentiviral expression vector containing the CaMKII promoter,
pFCK(0.4)GW was kindly provided by Pavel Osten (Max Planck Institute, Hei-
delberg; Dittgen et al., 2004). Lentiviral constructs were used to express an
EGFP-HCN1 fusion protein in which the C terminus of EGFP was fused to
the N terminus of HCN1, thus leaving the C-terminal -SNL tripeptide sequence
of the channel free to interact with TRIP8b (Santoro et al., 2004). Other lentiviral
constructs were used to express TRIP8b fusion proteins in which either the C
terminus of EGFP was fused to the N terminus of a given TRIP8b splice variant,
or the hemagglutinin epitope (HA) tag was fused to the C terminus of a given
TRIP8b splice variant (as indicated). Each lentiviral expression plasmid was
transfected into HEK293FT cells with virus packaging plasmids pVSVg and
pD8.9. After 24–48 hr, the culture media containing assembled viruses was
filtered, placed over a 20% sucrose cushion, and spun at 26000 rpm for 3 hr
to purify the virus. The pellet was resuspended in sterile saline and stored at
80C. Virus titers were measured using high-density cultured hippocampal
neurons. For in vivo delivery, virus was concentrated to 107 IU/ml in sterilesaline and stereotaxically injected into the hippocampal CA1 region of adult
mice (age 3–9 months) as described (Zakharenko et al., 2003). HCN1 knockout
animals (genotype HCN1/) were generated and bred as described (Nolan
et al., 2003). For each animal, four injections were performed: dorsal region
of left and right hippocampus, ventral region of left and right hippocampus.
Real-Time PCR
PolyA+ RNA from adult mouse brain (Clontech) was used to generate first
strand cDNA using random hexamer priming (Superscript, Invitrogen). Stan-
dard curves were generated using plasmids encoding the full-length sequence
for each TRIP8b variant (reference plasmid DNA), added in 4-fold increments
(15.6 fg, 62.5 fg, 250 fg, 1000 fg per reaction). A negative control without DNA
was run in all experiments, and reactions in which contaminating DNA copy
number exceeded 10% of the 15.6 fg titration point were eliminated. cDNA
was added to each reaction in 4-fold increments (corresponding to 1 ng, 4
ng, 16 ng of initial polyA+ RNA). For each isoform, two sets of primers were
used: an isoform specific set (spanning the exon-exon junctions corresponding
to that splice form) and a reference set amplifying a sequence in the common
region of TRIP8b mRNA (Table S1). For each determination, both sets were
run against the same reference plasmid DNA, as well as against the cDNA
sample, and values obtained for cDNA samples plotted against the standard
curve. Accordingly, the copy number of each splice variant is expressed as
a fraction of the total TRIP8b mRNA copy number, with both values determined
using the same reference plasmid DNA to correct for errors due to variability in
the purity of DNA. Only primer pairs yielding the same reaction efficiency when
tested against reference plasmid DNA or cDNA were used. All PCR experi-
ments were performed in a GeneAmp 5700 Sequence Detector from Applied
Biosystems (Foster City, CA). Samples were run in triplicate using SYBR Green
PCR Master Mix (Applied Biosystems). Reaction products were run on a 2%
agarose gel to check for expected amplicon size. In each case, a dissociation
(melting) curve was evaluated for the presence of a single final product.
Oocyte Electrophysiology
Two-microelectrode voltage-clamp recordings were obtained 3 days after
cRNA injection, using a Warner Instruments OC-725C amplifier. Data were
digitized and acquired with an ITC-16 interface (Instrutech), filtered at 1 kHz
and sampled at 2 kHz, and analyzed using Pulse software (HEKA). Microelec-
trodes filled with 3 M KCl had resistances of 0.5–2.0 MU. Oocytes were bathed
in extracellular solution containing (in mM): 94 NaCl, 4 KCl, 10 HEPES, and
2 MgCl2 (pH 7.5). This solution is more physiological than the isotonic KCl solu-
tion used in some of our previous studies and results in some differences in
HCN1 V1/2 values compared to prior work (e.g., Chen et al., 2001b). Three-
second-long voltage steps were applied in 10 mV increments from a holding
potential of30 mV. Peak tail-current amplitudes were measured at 0 mV after
the decay of the capacitive transient, and tail-current I-V curves fitted using the
Boltzmann equation: I(V) = A1 + A2/{1 + exp[(V-V1/2)/s]} in which A1 is the offset
caused by holding current, A2 is the maximal tail current amplitude, V is the
test pulse voltage, V1/2 is the midpoint voltage of activation, and s is the slope
(in mV). Time constants of Ih activation and deactivation were obtained by
fitting a single exponential function, I = I0exp(t/t), following an initial delay,
to current activation time courses during the hyperpolarizing steps and to
tail current decay following the step to 0 mV, respectively.
For inside-out patch clamp measurements, recordings were obtained
3–5 days after cRNA injections. Data were acquired, filtered, and analyzed
as described above. The pipette solution contained (in mM) 97 KCl, 1 NaCl,
10 HEPES, and 1 MgCl2, 1.8 CaCl2 (pH 7.4) with KOH; the bath solution con-
tained (in mM) 107 KCl, 5 NaCl, 10 HEPES, 1 MgCl2, and 1 EGTA (pH 7.3) with
KOH. The Ag-AgCl ground wire was connected to the bath solution by a 3 M
KCl agar bridge electrode. Three-second-long hyperpolarizing voltages were
applied in 10 mV step increments from a holding potential of 30 mV. Tail
currents were measured at 30 mV. All recordings were obtained at room
temperature (22C–24C).
Brain Extract Analysis and Immunohistochemistry
Brain tissue was homogenized in ice cold 10 mM Tris-HCl (pH7.4), 320 mM
sucrose, 5 mM EDTA, with protease inhibitor cocktail (CompleteMini, Roche)
in a glass-teflon-type homogenizer, centrifuged for 5 min at 3000 3 g, theNeuron 62, 802–813, June 25, 2009 ª2009 Elsevier Inc. 811
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HCN1 Regulation by TRIP8b Splice Variantssupernatant collected and spun for 20 min at 100,000 3 g. The pellet was
resuspended in homogenization buffer (as above) including 150 mM NaCl
and 1% Triton, and protein concentration determined using Micro BCA
reagent (Pierce). Immunoprecipitation was carried out on 100 mg of solubilized
membrane extract in 400 ml of homogenization buffer including 150 mM NaCl
and 0.2% Triton, overnight at 4C. Samples were eluted directly in 23 Laemmli
buffer, and western blotting was performed as described (Nolan et al., 2003).
Primary antibodies: rat monoclonal anti-HCN1 (7C3), gift of F. Mu¨ller and
B. Kaupp; rabbit polyclonal anti-TRIP8b (794, produced in our laboratory,
see below); mouse monoclonals anti-adaptin a, b, and g (all BD Biosciences).
Secondary antibodies: HRP-anti-rat conjugate, HRP-anti-mouse conjugate
(Jackson ImmunoResearch), HRP-anti-rabbit conjugate (Cell Signaling). Pro-
tein bands were visualized by chemiluminescence using SuperSignal reagent
(Pierce).
For immunohistochemistry, animals were perfused with ice-cold 13 PBS
followed by 4% paraformaldehyde in 13 PBS, 40 mm slices cut with a vibra-
tome and permeabilized in PBS + 0.1% Triton, followed by incubation in block-
ing solution (PBS + 3% normal goat serum). Primary antibody incubation was
carried out in blocking solution overnight at 4C. Antibodies used were: rat
monoclonal anti-HCN1 (7C3), rat monoclonal anti-HA (Roche), rabbit anti-
TRIP8b (794). Rhodamine-red conjugated goat anti-rat and Cy5-conjugated
goat anti-rabbit secondary antibodies were from Jackson ImmunoResearch;
GFP was visualized by direct fluorescence. Slices were mounted with Gel/
Mount (Biomeda, CA), and fluorescence imaging performed on an inverted
laser scanning confocal microscope (BioRad MRC 1000).
For antibody generation, a fragment corresponding to amino acids 1–176 of
TRIP8b(1a-4) was subcloned into vector pGEX-4T-1 (Pharmacia) and glutha-
tione-S-transferase (GST-)TRIP8b fusion protein purified as described (Santoro
et al., 1997, 2004). Polyclonal antibodies were generated in rabbit (Covance)and
serum 794 tested for specificity by western blot analysis using protein extracts
from Xenopus oocytes expressing each of the cloned TRIP8b isoforms. The
serum showed comparable affinity for all isoforms and recognized two promi-
nent protein species in extracts from mouse brain membranes (see Figure S2).
Hippocampal Cultures and Electrophysiology
The hippocampus was dissected from the brains of P0–P1 rats, digested with
papain, washed with protease inhibitor, then triturated, and neurons counted
and plated onto differentiated primary astrocyte feeder layers. Neurons were
grown in Neurobasal media supplemented with B27, glutamine, and antibi-
otics. Cultures were infected with lentivirus expressing either GFP or a GFP-
TRIP8b fusion construct under the control of a 0.4 kb fragment of the CaMKII
promoter (vector pFCK(0.4)GW, see above).
Hippocampal cultures were used for whole-cell recordings 7–17 days after
infection. Whole-cell patch recordings were obtained from pyramidal-shaped
neurons using 2–3 MU borosilicate glass pipettes. Intracellular solution was
(in mM) KMethylsulfate (130), KCl (10), HEPES (10), NaCl(4), EGTA (0.1), MgATP
(4), Na2GTP (0.3), Phosphocreatine (10). The external bath solution contained
(in mM) 145 NaCl, 3 KCl, 10 HEPES, 3 CaCl2, 8 glucose, 2 MgCl2 (pH adjusted
to 7.30 with NaOH). Only recordings with uncompensated whole-cell series
resistance below 15 MU were used for analysis. Series resistance compensa-
tion of 80%–90% was used. To eliminate spontaneous activity, 2 mM tetrodo-
toxin (TTX) was added to the bath solution after establishing that a cell
displayed the expected action potential shape and firing pattern for a pyramidal
neuron. All data were obtained in pairs, with one GFP-expressing neuron
matched with each GFP-TRIP8b expressing neuron, as described (Santoro
et. al 2004).
SUPPLEMENTAL DATA
Supplemental Data include one table and four figures and can be found with this
article online at http://www.cell.com/neuron/supplemental/S0896-6273(09)
00360-2.
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Note Added in Proof
A recent study reported that different TRIP8b isoforms upregulate surface
expression and have an inhibitory effect on gating of HCN1 channels in
HEK293 cells: Lewis, A.S., Schwartz, E., Chan, C.S., Noam, Y., Shin, M., Wad-
man, W.J., Surmeier, D.J., Baram, T.Z., Macdonald, R.L. and Chetkovich, D.M.
(2009). Alternatively spliced isoforms of TRIP8b differentially control h channel
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